These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16426578)

  • 1. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes.
    Tanaka Y; Marusawa H; Seno H; Matsumoto Y; Ueda Y; Kodama Y; Endo Y; Yamauchi J; Matsumoto T; Takaori-Kondo A; Ikai I; Chiba T
    Biochem Biophys Res Commun; 2006 Mar; 341(2):314-9. PubMed ID: 16426578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
    Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
    J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha.
    Sarkis PT; Ying S; Xu R; Yu XF
    J Immunol; 2006 Oct; 177(7):4530-40. PubMed ID: 16982890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
    Peng G; Lei KJ; Jin W; Greenwell-Wild T; Wahl SM
    J Exp Med; 2006 Jan; 203(1):41-6. PubMed ID: 16418394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of APOBEC3G in patients infected with hepatitis C virus.
    Komohara Y; Yano H; Shichijo S; Shimotohno K; Itoh K; Yamada A
    J Mol Histol; 2006 Nov; 37(8-9):327-32. PubMed ID: 17036163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
    Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.
    Rose KM; Marin M; Kozak SL; Kabat D
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):611-9. PubMed ID: 16060832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3G targets human T-cell leukemia virus type 1.
    Sasada A; Takaori-Kondo A; Shirakawa K; Kobayashi M; Abudu A; Hishizawa M; Imada K; Tanaka Y; Uchiyama T
    Retrovirology; 2005 May; 2():32. PubMed ID: 15943885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of APOBEC3G in kidney cells.
    Komohara Y; Suekane S; Noguchi M; Matsuoka K; Yamada A; Itoh K
    Tissue Antigens; 2007 Jan; 69(1):95-8. PubMed ID: 17212712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
    Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3G & HTLV-1: inhibition without deamination.
    Strebel K
    Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction of foamy viruses by APOBEC cytidine deaminases.
    Delebecque F; Suspène R; Calattini S; Casartelli N; Saïb A; Froment A; Wain-Hobson S; Gessain A; Vartanian JP; Schwartz O
    J Virol; 2006 Jan; 80(2):605-14. PubMed ID: 16378963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha induces high expression of APOBEC3G and STAT-1 in vitro and in vivo.
    Chen H; Wang LW; Huang YQ; Gong ZJ
    Int J Mol Sci; 2010 Sep; 11(9):3501-12. PubMed ID: 20957108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subcellular localization of APOBEC3G by confocal laser scanning microscope (CLSM)].
    Yang YS; Li L; Li ZL; Zeng Y
    Bing Du Xue Bao; 2007 Jan; 23(1):16-21. PubMed ID: 17886715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effect of APOBEC3G on Hepatitis B virus.
    Noguchi C; Hiraga N; Mori N; Tsuge M; Imamura M; Takahashi S; Fujimoto Y; Ochi H; Abe H; Maekawa T; Yatsuji H; Shirakawa K; Takaori-Kondo A; Chayama K
    J Gen Virol; 2007 Feb; 88(Pt 2):432-440. PubMed ID: 17251560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
    Franca R; Spadari S; Maga G
    Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC-mediated interference with hepadnavirus production.
    Rösler C; Köck J; Kann M; Malim MH; Blum HE; Baumert TF; von Weizsäcker F
    Hepatology; 2005 Aug; 42(2):301-9. PubMed ID: 16025511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle.
    Wang X; Dolan PT; Dang Y; Zheng YH
    J Biol Chem; 2007 Jan; 282(3):1585-94. PubMed ID: 17142455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
    Esnault C; Heidmann O; Delebecque F; Dewannieux M; Ribet D; Hance AJ; Heidmann T; Schwartz O
    Nature; 2005 Jan; 433(7024):430-3. PubMed ID: 15674295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.
    Kaiser SM; Emerman M
    J Virol; 2006 Jan; 80(2):875-82. PubMed ID: 16378989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.